Association between Alcohol Consumption and hsCRP in Korean Adults

한국 성인에서의 음주량과 hsCRP와의 관련성

Jo, Yang-Hyun;Cheong, Yoo-Seock;Park, Eal-Whan;Kim, Jae-Hun;Choi, Eun-Young
조양현;정유석;박일환;김재훈;최은영

  • Published : 20071000

Abstract

Association between Alcohol Consumption and hsCRP in Korean AdultsYang Hyun Jo, M.D., Eun Young Choi, M.D.†, Yoo Seock Cheong, M.D., Eal Whan Park, M.D., Jae Hun Kim, M.D.* Background: Cardiovascular diseases are major cause of death. In many countries, several studies reported moderate alcohol drink reduces cardiovascular diseases. High sensitivity C-reactive protein (hsCRP) is useful as a biochemical marker that can evaluate the risk of cardiovascular diseases. This study investigated the association between alcohol consumption and hsCRP. Methods: The subjects included 769 men and 449 women who had visited a health promotion center in one university hospital from May 2006 to June 2006. They responded to self-reported questionnaire on past medical history, quantity and frequency of alcohol intake. Blood sample was taken to examine hsCRP, total cholesterol, HDL cholesterol, and triglyceride. The participants were classified into 4 groups in males and 3 groups in females by alcohol intake quantity. Using general linear model, analysis of covariance was done to evaluate the association between hsCRP and alcohol intake quantity after adjusting for smoking, body mass index, blood pressure, age, total cholesterol, HDL cholesterol, and triglycerides. Results: Men who had drunk 1∼4 drinks weekly had the lowest hsCRP. And a U-shaped correlation between alcohol intake quantity and hsCRP was found (P for U- shape trend test=0.059). In women, hsCRP decreased as the alcohol intake quantity increased (P for linear trend test= 0.0002). Conclusion: In Korean males, U-shaped relationship was found between hsCRP and alcohol intake quantity. In Korean females, inverse relationship was found between them. (J Korean Acad Fam Med 2007;28:768-773)

연구배경: 심혈관 질환은 전체 사망원인의 21.2%로 주요 사망원인 중 하나이다. 많은 나라에서 적당량의 음주가 심혈관 질환의 발생을 줄인다는 연구가 보고되고 있으며, 심혈관 질환의 위험도를 객관적으로 평가할 수 있는 생화학적 염증표지자로 hsCRP (high sensitivity C-reactive protein)의 유용성이 인정받고 있다. 본 연구는 우리나라 성인에서 음주량와 hsCRP의 관련성에 대해서 조사하였다. 방법: 2006년 5월부터 6월까지 한 대학병원 종합건강검진센터를 방문한 남성 769명, 여성 449명, 총 1,218명을 대상으로 신체계측 및 혈압측정과 과거력, 현병력, 음주력에 대한 설문조사 및 hsCRP, 총콜레스테롤, 고밀도지단백, 중성지방을 측정하기 위해 혈액검사를 시행하였다. 대상자를 음주량과 음주횟수에 따라 남성에서는 4군, 여성에서는 3군으로 나누어 분석하였으며, 흡연, 혈압, 체질량지수, 나이, 총콜레스테롤, 중성지방, 고밀도지단백 등 hsCRP에 영향을 끼치는 요인을 보정한 후에 음주량이 hsCRP에 미치는 영향을 알아보기 위해 일반선형모델(GLM)을 이용한 공분산분석과 경향분석을 시행하였다. 결과: 음주량에 따른 분석 시에는 남성에서는 일주일에 1∼4잔을 마신 군에서 가장 낮은 hsCRP 값을 보였고 그 이전과 이후 다시 상승하는 U자형을 나타내었다(P for U-shape trend test=0.059). 여성에서는 음주량이 증가할수록 hsCRP 값은 감소하였다(P for linear trend test=0.0002). 결론: 남성에서 음주량과 hsCRP는 U자형의 관계를 보였으며, 여성에서는 반비례 관계를 나타냈다.

Keywords

References

  1. McGovern PG, Pankow JS, Shahar E, Doliszny KM, Folsom AR, Blackburn H, et al. Recent trends in acute coronary heart disease-- mortality, morbidity, medical care, and risk factors. The Minnesota Heart Survey Investigators. N Engl J Med 1996;334(14):884-90 https://doi.org/10.1056/NEJM199604043341403
  2. 통계청. 2004년 사망원인통계결과. 대전:통계청;2005
  3. Rimm EB, Giovannucci EL, Willett WC, Colditz GA, Ascherio A, Rosner B, et al. Prospective study of alcohol consumption and risk of coronary disease in men. Lancet 1991;338(8765):464-8 https://doi.org/10.1016/0140-6736(91)90542-W
  4. Albert CM, Manson JE, Cook NR, Ajani UA, Gaziano JM, Hennekens CH. Moderate alcohol consumption and the risk of sudden cardiac death among US male physicians. Circulation 1999;100(9):944-50 https://doi.org/10.1161/01.CIR.100.9.944
  5. Sacco RL, Elkind M, Boden-Albala B, Lin IF, Kargman DE, Hauser WA, et al. The protective effect of moderate alcohol consumption on ischemic stroke. JAMA 1999;281(1):53-60 https://doi.org/10.1001/jama.281.1.53
  6. Ridker PM, Glynn RJ, Hennekens CH. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation 1998;97(20):2007-11 https://doi.org/10.1161/01.CIR.97.20.2007
  7. Danesh J, Collins R, Appleby P, Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA 1998;279(18):1477-82 https://doi.org/10.1001/jama.279.18.1477
  8. Koenig W, Sund M, Froohlich M, Fischer HG, Lowel H, Doring A, et al. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (monitering trends and determinants in cardiovascular disease) Augsburg Cohort Study, 1984 to 1992. Circulation 1999; 99(2):237-42 https://doi.org/10.1161/01.CIR.99.2.237
  9. Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 1998;98(8):731-3 https://doi.org/10.1161/01.CIR.98.8.731
  10. Albert MA, Glynn RJ, Ridker PM. Alcohol consumption and plasma concentration of C-reactive protein. Circulation 2003; 107(3):443-7 https://doi.org/10.1161/01.CIR.0000045669.16499.EC
  11. Imhof A, Froehlich M, Brenner H, Boeing H, Pepys MB, Koenig W. Effect of alcohol consumption on systemic markers of inflammation. Lancet 2001;357(9258):763-7 https://doi.org/10.1016/S0140-6736(00)04170-2
  12. US Department of Agriculture. Dietary Guideline for Americans. USA:Department of Agriculture;2005
  13. Camargo CA Jr, Hennekens CH, Gaziano JM, Glynn RJ, Manson JE, Stampfer MJ. Prospective study of moderate alcohol consumption and mortality in US male physician. Arch Intern Med 1997;157(1):79-85 https://doi.org/10.1001/archinte.157.1.79
  14. Corrao G, Rubbiati L, Bagnardi V, Zambon A, Poikolainen K. Alcohol and coronary heart disease: a meta-analysis. Addiction 2000;95(10):1505-23 https://doi.org/10.1046/j.1360-0443.2000.951015056.x
  15. Rehm J, Sempos CT, Trevisan M. Alcohol and cardiovascular disease-more than one paradox to consider. Average volume of alcohol consumption, patterns of drinking and risk of coronary heart disease-a review. J Cardiovasc Risk 2003;10(1):15-20 https://doi.org/10.1097/00043798-200302000-00004
  16. Rimm EB, Williams P, Fosher K, Criqui M, Stampfer MJ. Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and hemostatic factors. BMJ 1999;319(7224):1523-8 https://doi.org/10.1136/bmj.319.7224.1523
  17. Mukamal KJ, Jadhav PP, D'Agostino RB, Massaro JM, Mittleman MA, Lipinska I, et al. Alcohol consumption and hemostatic factors: analysis of Framingham Offspring cohort. Circulation 2001;104(12):1367-73 https://doi.org/10.1161/hc3701.096067
  18. Agarwal DP. Cardioprotective effects of light-moderate consumption of alcohol: a review of putative mechanisms. Alcohol Alcohol 2002;37(5):409-15 https://doi.org/10.1093/alcalc/37.5.409
  19. Torzewski M, Rist C, Mortensen RF, Zwaka TP, Bienek M, Waltenberger J, et al. C-reactive protein in the arterial intima: role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis. Arterioscler Thromb Vasc Biol 2000;20(9):2094-99 https://doi.org/10.1161/01.ATV.20.9.2094
  20. Reynolds GD, Vance RP. C-reactive protein immunohistochemical localization in normal and atherosclerotic human aortas. Arch Pathol Lab Med 1987;111(3):265-9
  21. Hatanaka K, Li Xa, Masuda K, Yutani C, Yamamoto A. Immunohistochemical localization of C-reactive protein-binding sites in human atherosclerotic aortic lesions by a modified streptavidin-biotin-staining method. Pathol Int 1995;45(9): 635-41 https://doi.org/10.1111/j.1440-1827.1995.tb03515.x
  22. Zhang YX, Cliff WJ, Schoefl GI, Higgins G. Coronary C-reactive protein distribution: its relation to development of atherosclerosis. Atherosclerosis 1999;145(2):375-9 https://doi.org/10.1016/S0021-9150(99)00105-7
  23. Torzewski J, Torzewski M, Bowyer DE, Fröhlich M, Koenig W, Waltenberger J, et al. C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries. Arterioscler Thromb Vasc Biol 1998;18(9):1386-92 https://doi.org/10.1161/01.ATV.18.9.1386
  24. Mendall MA, Patel P, Ballam L, Strachan D, Northfield TC. C-reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. BMJ 1996; 312(7038):1061-4 https://doi.org/10.1136/bmj.312.7038.1061
  25. Mukamal KJ, Cushman M, Mittleman MA, Tracy RP, Siscovick DS. Alcohol consumption and inflammatory markers in older adults: the cardiovascular health study. Atherosclerosis 2004;173(1):79-87 https://doi.org/10.1016/j.atherosclerosis.2003.10.011
  26. Constant J. Alcohol, ischemic heart disease, and the French paradox. Clin Cardiol 1997;20(5):420-24 https://doi.org/10.1002/clc.4960200504
  27. McCarty MF. Interleukin-6 as a central mediator of cardiovascular risk associated with chronic inflammation, smoking, diabetes and visceral obesity: down-regulation with essential fatty-acids, ethanol and pentoxiphylline. Med Hypotheses 1999;52(5):465-77 https://doi.org/10.1054/mehy.1997.0684
  28. Averina M, Nilssen O, Arkhipovsky VL, Kalinin AG, Brox J. C-reactive protein and alcohol consumption: Is there a U-shaped association? Results from a population-based study in Russia. The Arkhangelsk study. Atherosclerosis 2006; 188(2):309-15 https://doi.org/10.1016/j.atherosclerosis.2005.11.007
  29. Davison S, Davis SR. New markers for cardiovascular disease risk in women: impact of endogenous estrogen status and exogenous postmenopausal hormone therapy. J Clin Endocrinol Metab 2003;88(6):2470-8 https://doi.org/10.1210/jc.2002-021929